STAT+: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny
WASHINGTON — Medical marijuana companies sell medicine, just like pharmaceutical companies. But they’re not playing…
Category: Medicine
STAT’s most memorable photos of 2023
The past year has brought huge changes in medicine and science — from innovations like…
Opinion: Why haven’t health care cost increases exceeded inflation? There’s a very good reason
All Americans are worried about inflation. The prices for housing, clothes and food at the…
.jpg)
STAT+: Drugs are still mostly tested in white men. Will the FDA change that next year?
WASHINGTON — Sometime next year drug and medical device companies will have to tell the…
After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes
Mary Brown was sipping coffee at home in Ontario, Calif., Sunday morning when a friend…
STAT+: SEC charges former CEO of pain relief device company with $41 million fraud
The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company…
Morning Rounds: Americans put faith in nurses as overall confidence in health care ebbs
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Inhaled vaccines could stop Covid infections, monkey studies show
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Curevac loses key patent in battle with BioNTech; Abernethy to step down as Verily CMO
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pharmalittle: Curevac loses key patent in battle with BioNTech; Abernathy to step down as Verily CMO
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: In another blow, Argenx antibody therapy fails in trial for skin blistering condition
LONDON — The Belgian company Argenx said Wednesday that its closely watched antibody therapy failed…
STAT+: 3 trends to watch in biotech in 2024
Every winter, like Punxsutawney nobles, biotech’s many thought leaders gather in San Francisco to pick…
Opinion: The U.S. must raise federal alcohol taxes to address the alarming rise in alcohol use
Eleven years ago, two days before Christmas, my 24-year-old brother, who was a university graduate…
A medical student was isolated by an autoimmune disorder. Poetry was a way out
When Leena Danawala’s poetry was published in JAMA last month, the medical journal became just…
Opinion: Racism infects neuroscience’s past and present. What about its future?
De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at…
Pregnant cancer patients often have to terminate. Abortion pill restrictions could make that choice even harder
WASHINGTON — The patient had already made the agonizing decision to start chemotherapy to address…
At a hospital’s teaching kitchen, patients get a taste of food as medicine
BOSTON — Tony McKoy, Jr. was ready to eat. Black chef’s hat on his head,…
STAT+: Amy Abernethy to step down as Verily’s chief medical officer in latest departure from company
Amy Abernethy, the president of product development and chief medical officer at Verily, a health…
U.S. government spent more on health care in 2022 than six countries with universal health care combined
American taxpayers footed the bill for at least $1.8 trillion in federal and state health…
Morning Rounds: Have regulations on digital trackers in health care gone too far?
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
.jpg)
The biotech updates you need to read today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors
Top of the morning to you. And a fine one it is. Lots of sunshine…
Opinion: There’s a public health crisis lurking in our data: the Census option ‘some other race’
According to the 2020 Census, the second most common race in America, after white, is…
STAT+: In the U.S., scientists see barriers to the development of CAR-T therapies. In Spain, a hospital brews its own
BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital…
What the new health counsels at FTC, DOJ, and HHS might do
Three major government agencies are adding new officials to investigate price-gouging in health care —…
Here are the worst biopharma CEOs of 2023
Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of…
STAT+: Health care industry fights back against crackdowns on health data tracking
Wherever you go on the internet, trackers follow. These ubiquitous bits of code, invisibly embedded…
STAT Virtual Event | Cancer’s Breakthrough Engine
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Biden administration asks judge to toss out Humana’s Medicare Advantage audit lawsuit
The Department of Justice has asked a federal judge to dismiss a lawsuit brought by…
STAT+: Apple pauses sales of latest watches in the US after ITC decision
Apple is temporarily pulling certain Apple Watches from the U.S. market to comply with an…
STAT+: Prime Medicine, Mukherjee’s Myeloid Therapeutics clash over genome-editing deal
The closely watched gene editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with…
STAT+: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds
As more data emerges that obesity drugs like Wegovy can reduce complications from heart and…
Morning Rounds: Why some doctors plan to quit their jobs
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Illumina will divest Grail after court finds deal was anti-competitive; FDA found problems at Moderna facility
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Structure Therapeutics GLP-1 pill cuts blood sugar, weight in early diabetes study
Structure Therapeutics said Monday that its experimental GLP-1 pill demonstrated a 1% lowering of blood…
Opinion: Alzheimer’s drug approvals show we need a reevaluation of patient advocacy
When faced with a loved one’s progressive neurodegenerative disease, like Alzheimer’s, or your child’s rare…
STAT+: Here are the best biopharma CEOs of 2023
It’s that time of the year again when I recognize the Best Biopharma CEO of…
STAT+: ‘We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA
Jamie Dubuque faces the future with a mixture of gratitude and trepidation. Her son, Declan,…
STAT+: New Jersey’s telehealth restrictions cut off access to lifesaving care, lawsuit alleges
Since states started rolling back pandemic-inspired flexibilities that allowed physicians to easily practice telehealth across…
STAT+: Illumina says it will divest Grail, starting a closing chapter for a disastrous deal
Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail,…
STAT+: The biggest health care deals of 2023
Every year, the health care industry behaves more and more like a balloon: Squeeze one…
Opinion: STAT readers on teaching medical students about intellectual disabilities, sobering centers, and annual wellness visits
STAT now publishes selected Letters to the Editor received in response to First Opinion essays…
Opinion: The WHO recognizes noma after years of medical-dental disconnect
Fidel Strub was 3 years old when his face began rotting away. “It’s hell. It’s…
NIH panel calls for fewer, better-paid postdocs in bid to halt loss of scientists to industry
A National Institutes of Health working group on Friday recommended a sizable increase in salaries…
Opinion: The Biden administration’s plan to use march-in rights to address drug prices would kill future world-changing innovations
The Bayh-Dole Act is widely credited with kickstarting a new era of American innovation involving the…
Morning Rounds: Americans’ health is trending downward, poll finds
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
FDA chastens pet companies over antibiotics
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Bluebird claims big insurer will cover its sickle cell therapy; House Republicans threaten to subpoena FDA commish
And so, another working week will soon draw to a close. Not a moment too…
STAT+: European regulators endorse Casgevy, paving way for approval of CRISPR-based therapy
LONDON — The world’s first medicine based on the genome-editing technology CRISPR will almost certainly…